Back to Search Start Over

Genetic invalidation of Lp-PLA

Authors :
John M, Gregson
Daniel F, Freitag
Praveen, Surendran
Nathan O, Stitziel
Rajiv, Chowdhury
Stephen, Burgess
Stephen, Kaptoge
Pei, Gao
James R, Staley
Peter, Willeit
Sune F, Nielsen
Muriel, Caslake
Stella, Trompet
Linda M, Polfus
Kari, Kuulasmaa
Jukka, Kontto
Markus, Perola
Stefan, Blankenberg
Giovanni, Veronesi
Francesco, Gianfagna
Satu, Männistö
Akinori, Kimura
Honghuang, Lin
Dermot F, Reilly
Mathias, Gorski
Vladan, Mijatovic
Patricia B, Munroe
Georg B, Ehret
Alex, Thompson
Maria, Uria-Nickelsen
Anders, Malarstig
Abbas, Dehghan
Thomas F, Vogt
Taishi, Sasaoka
Fumihiko, Takeuchi
Norihiro, Kato
Yoshiji, Yamada
Frank, Kee
Martina, Müller-Nurasyid
Jean, Ferrières
Dominique, Arveiler
Philippe, Amouyel
Veikko, Salomaa
Eric, Boerwinkle
Simon G, Thompson
Ian, Ford
J, Wouter Jukema
Naveed, Sattar
Chris J, Packard
Abdulla Al, Shafi Majumder
Dewan S, Alam
Panos, Deloukas
Heribert, Schunkert
Nilesh J, Samani
Sekar, Kathiresan
Børge G, Nordestgaard
Danish, Saleheen
Joanna Mm, Howson
Emanuele, Di Angelantonio
Adam S, Butterworth
John, Danesh
Source :
European journal of preventive cardiology. 24(5)
Publication Year :
2016

Abstract

Aims Darapladib, a potent inhibitor of lipoprotein-associated phospholipase A

Subjects

Subjects :
Adult
Male
Genotype
Phospholipase A2 Inhibitors
Reproducibility of Results
Coronary Disease
Middle Aged
Polymorphism, Single Nucleotide
Risk Assessment
Treatment Outcome
Gene Expression Regulation
Reference Values
Benzaldehydes
Case-Control Studies
1-Alkyl-2-acetylglycerophosphocholine Esterase
Oximes
Humans
Female
Molecular Targeted Therapy
Alleles
Aged
Randomized Controlled Trials as Topic

Details

ISSN :
20474881
Volume :
24
Issue :
5
Database :
OpenAIRE
Journal :
European journal of preventive cardiology
Accession number :
edsair.pmid..........42865f42e94e84613152c8d214a26980

Tools

Authors Abstract Subjects Details